Birdwatch Note
2024-10-21 15:41:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
敗血症はオミクロンにおいても新型コロナ感染後に見られやすい疾患です。 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944721/ こうした合併症が２回以上接種感染者とそれ以外の感染者でどちらが起きやすいかを調べた研究では後者の方で敗血症が起きやすかった事が報告済です 下記表1,2より前者が81/6774,後者が502/20859 https://www.sciencedirect.com/science/article/pii/S0264410X24001956?via%3Dihub
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848306061167763666
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1848389079265931640
- noteId - 1848389079265931640
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1729525272562
- tweetId - 1848306061167763666
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 敗血症はオミクロンにおいても新型コロナ感染後に見られやすい疾患です。 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944721/ こうした合併症が２回以上接種感染者とそれ以外の感染者でどちらが起きやすいかを調べた研究では後者の方で敗血症が起きやすかった事が報告済です 下記表1,2より前者が81/6774,後者が502/20859 https://www.sciencedirect.com/science/article/pii/S0264410X24001956?via%3Dihub
Note Ratings
| rated at | rated by | |
| 2024-10-21 22:07:56 -0500 | Rating Details | |
| 2024-10-21 20:56:31 -0500 | Rating Details | |
| 2024-10-21 19:28:43 -0500 | Rating Details | |
| 2024-10-21 21:20:27 -0500 | Rating Details | |
| 2024-10-21 17:39:41 -0500 | Rating Details | |
| 2024-10-21 17:10:31 -0500 | Rating Details | |
| 2024-10-21 22:24:53 -0500 | Rating Details | |
| 2024-10-21 22:23:54 -0500 | Rating Details | |
| 2024-10-21 20:03:35 -0500 | Rating Details | |
| 2024-10-21 17:25:23 -0500 | Rating Details | |
| 2024-10-21 11:36:22 -0500 | Rating Details | |
| 2024-10-21 22:59:25 -0500 | Rating Details | |
| 2024-10-21 16:56:46 -0500 | Rating Details | |
| 2024-10-21 16:47:43 -0500 | Rating Details | |
| 2024-10-21 13:09:32 -0500 | Rating Details | |
| 2024-10-21 11:47:32 -0500 | Rating Details |